Batra J K, Lin C M, Hamel E
Laboratory of Pharmacology and Experimental Therapeutics, National Cancer Institute, Bethesda, Maryland 20892.
Biochemistry. 1987 Sep 8;26(18):5925-31. doi: 10.1021/bi00392a052.
Pursuing the observation of Carlier and Pantaloni [Carlier, M.-F., & Pantaloni, D. (1982) Biochemistry 21, 1215-1224] that adenosine 5'-(beta, gamma-imidotriphosphate) (pNHppA) strongly inhibited tubulin-independent phosphatases in microtubule protein preparations, we observed with a number of commercial preparations of pNHppA that a major proportion of the terminal phosphate of [gamma-32P]GTP added to microtubule protein preparations was rapidly converted into ATP. Initially postulating degradation of pNHppA to AMP followed by stepwise conversion of AMP to ATP, we isolated two nucleoside monophosphate kinase activities from microtubule protein capable of generating ATP from AMP + GTP. The amounts of these enzymes in microtubule protein preparations, however, are probably too low to account for rapid ATP formation. Instead, ATP formation most likely is caused by nucleoside diphosphate kinase acting on ADP contaminating commercial pNHppA preparations. Such ADP contamination was demonstrated by high-performance liquid chromatography, with the amount of ATP formed with different pNHppA preparations proportional to the amount of ADP contamination. Repurification of commercial pNHppA until it was free of contaminating ADP also resulted in the elimination of ATP formation. The repurified pNHppA potently inhibited GTP hydrolysis in microtubule protein preparations. In addition, especially when supplemented with equimolar Mg2+, the repurified pNHppA strongly inhibited GTP hydrolysis and microtubule assembly in reaction mixtures containing purified tubulin and heat-treated microtubule-associated proteins (which contain negligible amounts of tubulin-independent phosphatase activity). We conclude that studies of microtubule-dependent GTP hydrolysis which make use of pNHppA must be interpreted with extreme caution.
基于卡利尔和潘塔洛尼的观察结果[卡利尔,M.-F.,& 潘塔洛尼,D.(1982年)《生物化学》21卷,1215 - 1224页],即腺苷5'-(β,γ-亚氨三磷酸)(pNHppA)强烈抑制微管蛋白制剂中不依赖微管蛋白的磷酸酶,我们在多种市售的pNHppA制剂中观察到,添加到微管蛋白制剂中的[γ-32P]GTP的大部分末端磷酸迅速转化为ATP。最初推测pNHppA降解为AMP,随后AMP逐步转化为ATP,我们从微管蛋白中分离出两种核苷单磷酸激酶活性,它们能够从AMP + GTP生成ATP。然而,微管蛋白制剂中这些酶的量可能太低,无法解释ATP的快速形成。相反,ATP的形成很可能是由核苷二磷酸激酶作用于污染市售pNHppA制剂的ADP所致。高效液相色谱法证实了这种ADP污染,不同pNHppA制剂形成的ATP量与ADP污染量成正比。将市售pNHppA重新纯化直至不含污染的ADP,也导致ATP形成的消除。重新纯化的pNHppA有效抑制了微管蛋白制剂中的GTP水解。此外,特别是在补充了等摩尔的Mg2+时,重新纯化的pNHppA强烈抑制了含有纯化微管蛋白和热处理的微管相关蛋白(其含有可忽略不计的不依赖微管蛋白的磷酸酶活性)的反应混合物中的GTP水解和微管组装。我们得出结论,利用pNHppA进行的微管依赖性GTP水解研究必须极其谨慎地进行解释。